Number in study | 1453 |
---|---|
Study arm, number (%) | |
Facility | 594 (41) |
Home | 859 (59) |
Women, number (%) | 1031 (71) |
Age in years, median (IQR) | 38 (32-44) |
Education level, number (%) | |
No education | 234 (16) |
Primary | 816 (56) |
Secondary/tertiary | 403 (28) |
Clients' main occupation, number (%) | |
Business/self employed/professional | 615 (42) |
Farmer | 389 (27) |
Unemployed/Housewife | 434 (30) |
Other | 15 (1) |
WHO stage, number (%) | |
I | 20 (1) |
II | 642 (44) |
III | 673 (46) |
IV | 118 (8) |
CD4 cell count cells/μl at enrolment, number (%) | |
< 50 | 444 (30) |
50-99 | 232 (16) |
100-200 | 654 (45) |
> 200 | 123 (9) |
Median (IQR) cells/μl | 108 (35-165) |
Plasma viral load copies/ml, number (%) | |
< 1,000 | 21 (2) |
1,000-9,999 | 40 (3) |
10,000-99,999 | 454 (31) |
100,000-999,999 | 832 (57) |
> = 1,000,000 | 106 |
Median (IQR), copies/ml | 163,224 (63,616-370,412) |
On cotrimoxazole prophylaxis, number (%) | 1403 (97%) |
Haemoglobin g/dl, number (%) * | |
≥ 11 | 701 (48%) |
9.5 - 10.9 | 407 (28%) |
8.0 - 9.4 | 242 (17%) |
6.5 - 7.9 | 80 (6%) |
< 6.5 | 19 (1%) |
Median g/dl (IQR) | 10.9 (IQR 9.5 - 12.3) |
Weight, kg, number (%) | |
< 50 | 431 (30%) |
50-60 | 698 (48%) |
> 60 | 317 (22%) |
Mean kg (sd) | 54.2 (9.2) |